Amanda Morgan
Corporate Officer/Principal bei LANTHEUS HOLDINGS, INC.
Vermögen: 2 Mio $ am 30.04.2024
Profil
Amanda Morgan is currently the Chief Commercial Officer at Lantheus Holdings, Inc. She previously worked as the Vice President-Sales & Market Access at ACADIA Pharmaceuticals, Inc. from 2017 to 2019.
Before that, she was the Head-Patient Services at Baxalta, Inc. from 2012 to 2016.
Amanda also served as the Vice President-U.S.
Sales at Baxter & Co. from 2008 to 2012.
She obtained her undergraduate degree from the University of Iowa in 2000.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
LANTHEUS HOLDINGS INC
0,04% | 25.03.2024 | 25 411 ( 0,04% ) | 2 Mio $ | 30.04.2024 |
Aktive Positionen von Amanda Morgan
| Unternehmen | Position | Beginn |
|---|---|---|
| LANTHEUS HOLDINGS, INC. | Corporate Officer/Principal | 29.11.2022 |
Ehemalige bekannte Positionen von Amanda Morgan
| Unternehmen | Position | Ende |
|---|---|---|
| BAXALTA INC | Corporate Officer/Principal | 01.03.2016 |
Baxter & Co.
 Baxter & Co. Other Consumer ServicesConsumer Services Baxter & Co. provides beauty care and hairdressing services. The private company is based in Franklin, TN. | Vertrieb & Marketing | 01.09.2012 |
| ACADIA PHARMACEUTICALS INC. | Corporate Officer/Principal | - |
Ausbildung von Amanda Morgan
| University of Iowa | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ACADIA PHARMACEUTICALS INC. | Health Technology |
| LANTHEUS HOLDINGS, INC. | Health Technology |
| Private Unternehmen | 2 |
|---|---|
Baxter & Co.
Baxter & Co. Other Consumer ServicesConsumer Services Baxter & Co. provides beauty care and hairdressing services. The private company is based in Franklin, TN. | Consumer Services |
Baxalta, Inc.
 Baxalta, Inc. BiotechnologyHealth Technology Baxalta, Inc. engages in the research, development, and manufacture of biopharmaceutical products. Its portfolio includes treatments for hemophilia, bleeding disorders, immune deficiencies, alpha-1 antitrypsin deficiency, burns, and shock. The company was founded on March 13, 2015 and is headquartered in Chicago, IL. | Health Technology |
